COVID-19 drug Paxlovid linked to multiple heart risks
As the world continues to navigate through the COVID-19 pandemic, the introduction of Paxlovid, a promising treatment option, has been a beacon of hope...
Scientists find the key to fighting evolving COVID-19
As COVID-19 continues to change, researchers are keeping a close eye on the virus and how vaccines stack up against new variants. A recent...
Man with over 200 COVID-19 shots shows surprising immune response
In an unusual case that caught the attention of researchers in Germany, a man has taken more than 200 COVID-19 vaccinations for personal reasons,...
COVID-19 virus can stay in the body more than 1 year, study finds
Researchers from UC San Francisco have made a startling discovery that could help explain why some people suffer from long COVID, a condition where...
Chronic fatigue could be a sign of long COVID
Recent research from La Trobe University has made significant strides in understanding the complex relationship between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID,...
Latest vaccines and treatments cut COVID-19 risks
A recent study by the Cleveland Clinic, shared in The Lancet Infectious Diseases, brings hopeful news in the fight against COVID-19.
The research shows that...
Scientists find key trigger of long COVID
New research has identified a potential key factor in the development of long COVID: problems with iron regulation and inflammation due to SARS-CoV-2 infection.
This...
Long COVID linked to cognitive declines, study finds
Recent research has shed light on another potential impact of Long COVID: a decrease in cognitive abilities, or what many refer to as "brain...
Healthy runner’s stroke followed a bad bout of COVID-19
On a ride to high school one morning, Shelley Marshall asked her daughter how things were going with her field hockey team.
At least, that's...
People may need longer treatment for COVID-19, study shows
A recent study involving UCL researchers and published in Nature Communications suggests that the current five-day treatment regimen with the antiviral drug molnupiravir may...